Scholarlink

Background <p>Extracellular vesicles (EVs) derived from human umbilical cord Mesenchymal Stem Cells (hUCMSC-EVs) are emerging as promising immunomodulatory agents in inflammatory disorders. However, their potential for infectious diseases remains poorly explored.</p> Methods <p>We investigated the effects of hUCMSC-EVs in experimental Cutaneous Leishmaniasis (CL) caused by <i>Leishmania braziliensis</i> using both in vitro and in vivo approaches. EVs were isolated and characterized according to MISEV guidelines. Their immunomodulatory properties were evaluated in murine macrophages, and their therapeutic efficacy was tested in a preclinical model of CL.</p> Results <p>Treatment with hUCMSC-EV modulated the phenotype of <i>L. braziliensis</i>-infected bone marrow-derived macrophages toward a mixed M1/M2 profile, enhancing TNF-α and IL-10 secretion and reducing intracellular parasite load. Protemic analysis of the EV content was correlated with response to wounding and wound healing biological processes, which were confirmed in scratch and cell migration assays. In vivo, intravenous administration of hUCMSC-EV to infected mice reduced lesion thickness and collagen deposition at the infection site.</p> Conclusion <p>Our findings demonstrate that stimulation with hUCMSC-EVs enhanced <i>Leishmania</i> killing, inducing the upregulation of immune mediators. hUCMSC-EVs also promoted wound closure and keratinocyte migration. In vivo, intravenous injection of hUCMSC-EVs impaired lesion development, supporting their potential as an adjunctive therapy for CL. This study lays the groundwork for further investigation into MSC-EVs in host-directed therapies for infectious diseases.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Immunomodulatory and regenerative effects of human umbilical cord MSC-EVs in Cutaneous Leishmaniasis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月21日

查看全文
  • Pedro B. Borba,
  • Caio L. M. Torres,
  • Maria Vitória M. da Costa,
  • Yasmim Luz,
  • Kátia Nunes da Silva,
  • Sthefany da Conceição Pires,
  • Erick Correia Loiola,
  • Júlio César Queiroz Figueiredo,
  • Luciano de Souza Santos,
  • Gisele Vieira Rocha,
  • Juliana P. B. Menezes,
  • Zaquer Suzana Munhoz Costa-Ferro,
  • Bruno Solano de Freitas Souza,
  • Camila I. de Oliveira

摘要

Background

Extracellular vesicles (EVs) derived from human umbilical cord Mesenchymal Stem Cells (hUCMSC-EVs) are emerging as promising immunomodulatory agents in inflammatory disorders. However, their potential for infectious diseases remains poorly explored.

Methods

We investigated the effects of hUCMSC-EVs in experimental Cutaneous Leishmaniasis (CL) caused by Leishmania braziliensis using both in vitro and in vivo approaches. EVs were isolated and characterized according to MISEV guidelines. Their immunomodulatory properties were evaluated in murine macrophages, and their therapeutic efficacy was tested in a preclinical model of CL.

Results

Treatment with hUCMSC-EV modulated the phenotype of L. braziliensis-infected bone marrow-derived macrophages toward a mixed M1/M2 profile, enhancing TNF-α and IL-10 secretion and reducing intracellular parasite load. Protemic analysis of the EV content was correlated with response to wounding and wound healing biological processes, which were confirmed in scratch and cell migration assays. In vivo, intravenous administration of hUCMSC-EV to infected mice reduced lesion thickness and collagen deposition at the infection site.

Conclusion

Our findings demonstrate that stimulation with hUCMSC-EVs enhanced Leishmania killing, inducing the upregulation of immune mediators. hUCMSC-EVs also promoted wound closure and keratinocyte migration. In vivo, intravenous injection of hUCMSC-EVs impaired lesion development, supporting their potential as an adjunctive therapy for CL. This study lays the groundwork for further investigation into MSC-EVs in host-directed therapies for infectious diseases.